Nihon Kohden (OTCMKTS:NHNKY – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.24 by $0.10, Zacks reports. The company had revenue of $453.10 million during the quarter, compared to the consensus estimate of $414.40 million. Nihon Kohden had a net margin of 6.08% and a return on equity of 9.48%.
Nihon Kohden Stock Performance
Shares of OTCMKTS NHNKY traded up $0.59 during midday trading on Friday, reaching $9.30. The stock had a trading volume of 13,307 shares, compared to its average volume of 22,619. The company’s 50 day moving average price is $9.44 and its 200 day moving average price is $10.50. Nihon Kohden has a twelve month low of $8.71 and a twelve month high of $14.21. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of 15.77 and a beta of 0.41.
Wall Street Analysts Forecast Growth
A number of brokerages recently issued reports on NHNKY. UBS Group upgraded shares of Nihon Kohden from a “hold” rating to a “strong-buy” rating in a report on Monday, January 19th. Zacks Research upgraded shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Buy”.
Nihon Kohden Company Profile
Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.
The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.
Featured Stories
- Five stocks we like better than Nihon Kohden
- 3 Stocks to Own If Gas Prices Keep Rising
- 3 Crucial Aerospace Component Makers That Analysts Love
- Alphabet’s Googlebook Brings Gemini AI to PC Hardware
- Peloton Stock Gives Back Gains After Upbeat Earnings Report
Receive News & Ratings for Nihon Kohden Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nihon Kohden and related companies with MarketBeat.com's FREE daily email newsletter.
